https://stock.noler.com/us/stock/principia-biopharma-inc https://stock.noler.com/us/stock/principia-biopharma-inc/accounts-and-other-receivables-net-current https://stock.noler.com/us/stock/principia-biopharma-inc/accounts-payable https://stock.noler.com/us/stock/principia-biopharma-inc/accounts-receivable-related-parties-current https://stock.noler.com/us/stock/principia-biopharma-inc/accretion-amortization-of-discounts-and-premiums-investments https://stock.noler.com/us/stock/principia-biopharma-inc/accrued-employee-benefits-current https://stock.noler.com/us/stock/principia-biopharma-inc/accrued-liabilities-current https://stock.noler.com/us/stock/principia-biopharma-inc/accumulated-depreciation https://stock.noler.com/us/stock/principia-biopharma-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/principia-biopharma-inc/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/principia-biopharma-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/principia-biopharma-inc/aoci https://stock.noler.com/us/stock/principia-biopharma-inc/available-for-sale-debt-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/principia-biopharma-inc/available-for-sale-debt-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/principia-biopharma-inc/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/principia-biopharma-inc/available-for-sale-debt-current https://stock.noler.com/us/stock/principia-biopharma-inc/available-for-sale-debt-securities https://stock.noler.com/us/stock/principia-biopharma-inc/available-for-sale-debt-unrealized-loss-position https://stock.noler.com/us/stock/principia-biopharma-inc/available-for-sale-in-unrealized-loss-positions-qualitative-disclosure-number-of-positions https://stock.noler.com/us/stock/principia-biopharma-inc/available-for-sale-unrealized-loss-position-fair-value https://stock.noler.com/us/stock/principia-biopharma-inc/basic-shares https://stock.noler.com/us/stock/principia-biopharma-inc/capital-expenditures https://stock.noler.com/us/stock/principia-biopharma-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/principia-biopharma-inc/cash-and-equivalents https://stock.noler.com/us/stock/principia-biopharma-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/principia-biopharma-inc/cash-cash-equivalents-and-short-term-investments https://stock.noler.com/us/stock/principia-biopharma-inc/cash-flow-breakdown https://stock.noler.com/us/stock/principia-biopharma-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/principia-biopharma-inc/common-stock-value https://stock.noler.com/us/stock/principia-biopharma-inc/comprehensive-income https://stock.noler.com/us/stock/principia-biopharma-inc/contract-with-customer-performance-obligation-satisfied-in-previous-period https://stock.noler.com/us/stock/principia-biopharma-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/principia-biopharma-inc/current-assets https://stock.noler.com/us/stock/principia-biopharma-inc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/principia-biopharma-inc/current-foreign-tax-expense-benefit https://stock.noler.com/us/stock/principia-biopharma-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/principia-biopharma-inc/current-liabilities https://stock.noler.com/us/stock/principia-biopharma-inc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/principia-biopharma-inc/debt-conversion-converted-instrument-amount https://stock.noler.com/us/stock/principia-biopharma-inc/debt-convertible-beneficial-conversion-feature https://stock.noler.com/us/stock/principia-biopharma-inc/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/principia-biopharma-inc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/principia-biopharma-inc/deferred-foreign-income-tax-expense-benefit https://stock.noler.com/us/stock/principia-biopharma-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/principia-biopharma-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/principia-biopharma-inc/deferred-rent-credit https://stock.noler.com/us/stock/principia-biopharma-inc/deferred-rent-credit-current https://stock.noler.com/us/stock/principia-biopharma-inc/deferred-rent-credit-noncurrent https://stock.noler.com/us/stock/principia-biopharma-inc/deferred-revenue https://stock.noler.com/us/stock/principia-biopharma-inc/deferred-revenue-noncurrent https://stock.noler.com/us/stock/principia-biopharma-inc/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/principia-biopharma-inc/deferred-tax-assets-deferred-income https://stock.noler.com/us/stock/principia-biopharma-inc/deferred-tax-assets-goodwill-and-intangible-assets https://stock.noler.com/us/stock/principia-biopharma-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/principia-biopharma-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/principia-biopharma-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/principia-biopharma-inc/deferred-tax-assets-operating-loss-carryforwards-domestic https://stock.noler.com/us/stock/principia-biopharma-inc/deferred-tax-assets-operating-loss-carryforwards-state-and-local https://stock.noler.com/us/stock/principia-biopharma-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/principia-biopharma-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-other https://stock.noler.com/us/stock/principia-biopharma-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/principia-biopharma-inc/deferred-tax-liabilities-goodwill-and-intangible-assets-intangible-assets https://stock.noler.com/us/stock/principia-biopharma-inc/deposits-assets-noncurrent https://stock.noler.com/us/stock/principia-biopharma-inc/depreciation https://stock.noler.com/us/stock/principia-biopharma-inc/diluted-shares https://stock.noler.com/us/stock/principia-biopharma-inc/dilutive-shares https://stock.noler.com/us/stock/principia-biopharma-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/principia-biopharma-inc/effective-tax-rate https://stock.noler.com/us/stock/principia-biopharma-inc/embedded-derivative-fair-value-of-embedded-derivative-liability https://stock.noler.com/us/stock/principia-biopharma-inc/eps https://stock.noler.com/us/stock/principia-biopharma-inc/eps-basic https://stock.noler.com/us/stock/principia-biopharma-inc/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/principia-biopharma-inc/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/principia-biopharma-inc/financing-cash-flow https://stock.noler.com/us/stock/principia-biopharma-inc/foreign-pretax-income https://stock.noler.com/us/stock/principia-biopharma-inc/form-d-other https://stock.noler.com/us/stock/principia-biopharma-inc/form-d-stocks https://stock.noler.com/us/stock/principia-biopharma-inc/general-and-administrative-expense https://stock.noler.com/us/stock/principia-biopharma-inc/income-loss-from-per-basic-and-diluted-share https://stock.noler.com/us/stock/principia-biopharma-inc/income-tax https://stock.noler.com/us/stock/principia-biopharma-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/principia-biopharma-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/principia-biopharma-inc/increase-decrease-in-contract-with-customer-liability https://stock.noler.com/us/stock/principia-biopharma-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/principia-biopharma-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/principia-biopharma-inc/insider-transactions-preferred https://stock.noler.com/us/stock/principia-biopharma-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/principia-biopharma-inc/insider-transactions-stock-options/purchases https://stock.noler.com/us/stock/principia-biopharma-inc/insider-transactions-warrants https://stock.noler.com/us/stock/principia-biopharma-inc/interest-expense-on-debt https://stock.noler.com/us/stock/principia-biopharma-inc/interest-income-expense-nonoperating-net https://stock.noler.com/us/stock/principia-biopharma-inc/investing-cash-flow https://stock.noler.com/us/stock/principia-biopharma-inc/investment-income-interest https://stock.noler.com/us/stock/principia-biopharma-inc/lessee-operating-lease-discount-rate https://stock.noler.com/us/stock/principia-biopharma-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/principia-biopharma-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/principia-biopharma-inc/marketable-securities-current https://stock.noler.com/us/stock/principia-biopharma-inc/marketable-securities-gain-loss https://stock.noler.com/us/stock/principia-biopharma-inc/marketable-securities-noncurrent https://stock.noler.com/us/stock/principia-biopharma-inc/marketable-securities-unrealized-gain-loss https://stock.noler.com/us/stock/principia-biopharma-inc/net-change-in-cash https://stock.noler.com/us/stock/principia-biopharma-inc/net-income https://stock.noler.com/us/stock/principia-biopharma-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/principia-biopharma-inc/number-of-operating-segments https://stock.noler.com/us/stock/principia-biopharma-inc/oci-available-for-sale-adjustment-net-of-tax https://stock.noler.com/us/stock/principia-biopharma-inc/oci-available-for-sale-adjustment-net-of-tax-2 https://stock.noler.com/us/stock/principia-biopharma-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/principia-biopharma-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax-2 https://stock.noler.com/us/stock/principia-biopharma-inc/operating-cash-flow https://stock.noler.com/us/stock/principia-biopharma-inc/operating-expenses https://stock.noler.com/us/stock/principia-biopharma-inc/operating-income https://stock.noler.com/us/stock/principia-biopharma-inc/operating-lease-assets https://stock.noler.com/us/stock/principia-biopharma-inc/operating-lease-expense https://stock.noler.com/us/stock/principia-biopharma-inc/operating-lease-liability https://stock.noler.com/us/stock/principia-biopharma-inc/operating-lease-liability-current https://stock.noler.com/us/stock/principia-biopharma-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/principia-biopharma-inc/operating-lease-payments https://stock.noler.com/us/stock/principia-biopharma-inc/operating-lease-payments-due https://stock.noler.com/us/stock/principia-biopharma-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/principia-biopharma-inc/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/principia-biopharma-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/principia-biopharma-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/principia-biopharma-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/principia-biopharma-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/principia-biopharma-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/principia-biopharma-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/principia-biopharma-inc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/principia-biopharma-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/principia-biopharma-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/principia-biopharma-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/principia-biopharma-inc/operating-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/principia-biopharma-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/principia-biopharma-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/principia-biopharma-inc/other-noncurrent-assets https://stock.noler.com/us/stock/principia-biopharma-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/principia-biopharma-inc/other-than-temporary-impairment-loss-debt-securities-available-for-sale https://stock.noler.com/us/stock/principia-biopharma-inc/other-than-temporary-impairment-losses-investments-available-for-sale-securities https://stock.noler.com/us/stock/principia-biopharma-inc/paid-in-capital-convertible-debt-with-conversion-feature https://stock.noler.com/us/stock/principia-biopharma-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/principia-biopharma-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/principia-biopharma-inc/payments-for-proceeds-from-tenant-allowance https://stock.noler.com/us/stock/principia-biopharma-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/principia-biopharma-inc/payments-to-acquire-marketable-securities https://stock.noler.com/us/stock/principia-biopharma-inc/payments-to-acquire-short-term-investments https://stock.noler.com/us/stock/principia-biopharma-inc/preferred-shares-facts https://stock.noler.com/us/stock/principia-biopharma-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/principia-biopharma-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/principia-biopharma-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/principia-biopharma-inc/prepaid-expense-current https://stock.noler.com/us/stock/principia-biopharma-inc/pretax-income https://stock.noler.com/us/stock/principia-biopharma-inc/pretax-income-domestic https://stock.noler.com/us/stock/principia-biopharma-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/principia-biopharma-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/principia-biopharma-inc/proceeds-from-issuance-of-convertible-preferred-stock https://stock.noler.com/us/stock/principia-biopharma-inc/proceeds-from-issuance-of-debt https://stock.noler.com/us/stock/principia-biopharma-inc/proceeds-from-issuance-of-shares-under-incentive-and-share-based-compensation-plans-including-stock-options https://stock.noler.com/us/stock/principia-biopharma-inc/proceeds-from-sale-and-maturity-of-marketable-securities https://stock.noler.com/us/stock/principia-biopharma-inc/proceeds-from-sale-of-available-for-sale-debt https://stock.noler.com/us/stock/principia-biopharma-inc/proceeds-from-sale-of-short-term-investments https://stock.noler.com/us/stock/principia-biopharma-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/principia-biopharma-inc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/principia-biopharma-inc/profit-loss https://stock.noler.com/us/stock/principia-biopharma-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/principia-biopharma-inc/property-plant-equipment https://stock.noler.com/us/stock/principia-biopharma-inc/public-float https://stock.noler.com/us/stock/principia-biopharma-inc/realized-gains-on-securities https://stock.noler.com/us/stock/principia-biopharma-inc/research-and-development https://stock.noler.com/us/stock/principia-biopharma-inc/restricted-cash https://stock.noler.com/us/stock/principia-biopharma-inc/restricted-cash-current https://stock.noler.com/us/stock/principia-biopharma-inc/restricted-cash-noncurrent https://stock.noler.com/us/stock/principia-biopharma-inc/retained-earnings https://stock.noler.com/us/stock/principia-biopharma-inc/revenue https://stock.noler.com/us/stock/principia-biopharma-inc/revenue-from-contract-with-customer-excluding-assessed-tax https://stock.noler.com/us/stock/principia-biopharma-inc/shareholders-equity https://stock.noler.com/us/stock/principia-biopharma-inc/shares-authorized https://stock.noler.com/us/stock/principia-biopharma-inc/shares-issued https://stock.noler.com/us/stock/principia-biopharma-inc/short-term-investments https://stock.noler.com/us/stock/principia-biopharma-inc/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/principia-biopharma-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/principia-biopharma-inc/stock-award-options-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/principia-biopharma-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/principia-biopharma-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/principia-biopharma-inc/stock-based-compensation https://stock.noler.com/us/stock/principia-biopharma-inc/stock-compensation-tax-benefit-from-compensation-expense https://stock.noler.com/us/stock/principia-biopharma-inc/stock-compensation-tax-benefit-from-exercise-of-stock-options https://stock.noler.com/us/stock/principia-biopharma-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/principia-biopharma-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/principia-biopharma-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/principia-biopharma-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/principia-biopharma-inc/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/principia-biopharma-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/principia-biopharma-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/principia-biopharma-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/principia-biopharma-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/principia-biopharma-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/principia-biopharma-inc/stock-options-expirations-in-period https://stock.noler.com/us/stock/principia-biopharma-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/principia-biopharma-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/principia-biopharma-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/principia-biopharma-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/principia-biopharma-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/principia-biopharma-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/principia-biopharma-inc/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/principia-biopharma-inc/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/principia-biopharma-inc/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/principia-biopharma-inc/stock-options-vested-in-period-fair-value https://stock.noler.com/us/stock/principia-biopharma-inc/stock-split-ratio https://stock.noler.com/us/stock/principia-biopharma-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/principia-biopharma-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/principia-biopharma-inc/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/principia-biopharma-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/principia-biopharma-inc/tax-rate-reconciliation-share-based-compensation-excess-tax-benefit-percent https://stock.noler.com/us/stock/principia-biopharma-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/principia-biopharma-inc/tax-rate-reconciliation-tax-contingencies https://stock.noler.com/us/stock/principia-biopharma-inc/tax-rate-reconciliation-tax-credits https://stock.noler.com/us/stock/principia-biopharma-inc/temporary-equity-carrying-amount-attributable-to-parent https://stock.noler.com/us/stock/principia-biopharma-inc/temporary-equity-liquidation-preference https://stock.noler.com/us/stock/principia-biopharma-inc/temporary-equity-par-or-stated-value-per-share https://stock.noler.com/us/stock/principia-biopharma-inc/temporary-equity-shares-authorized https://stock.noler.com/us/stock/principia-biopharma-inc/temporary-equity-shares-issued https://stock.noler.com/us/stock/principia-biopharma-inc/temporary-equity-shares-outstanding https://stock.noler.com/us/stock/principia-biopharma-inc/total-assets https://stock.noler.com/us/stock/principia-biopharma-inc/total-liabilities https://stock.noler.com/us/stock/principia-biopharma-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/principia-biopharma-inc/undistributed-earnings-loss-allocated-to-participating-securities-basic https://stock.noler.com/us/stock/principia-biopharma-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/principia-biopharma-inc/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/principia-biopharma-inc/utb-income-tax-penalties-and-interest-expense https://stock.noler.com/us/stock/principia-biopharma-inc/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/principia-biopharma-inc/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/principia-biopharma-inc/utb-that-would-impact-effective-tax-rate https://stock.noler.com/us/stock/principia-biopharma-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/principia-biopharma-inc/warrants-and-rights-outstanding https://stock.noler.com/us/stock/principia-biopharma-inc/weighted-average-number-of-share-outstanding-basic-and-diluted